Skip to content
Search AI Powered

Latest Stories

Veterans Denied: Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

Republicans Strike Down All Marijuana And Psychedelics Amendments From NDAA

Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing
Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

As the National Defense Authorization Act (NDAA) takes center stage in shaping the future of the United States Department of Defense, Congress missed a crucial opportunity to prioritize the well-being of our nation's veterans. 

Amendments that would have expanded access to cannabis and psychedelics for medical purposes were recently rejected in a Rules Committee vote, leaving veterans stranded in their ongoing battle against post-traumatic stress disorder (PTSD) and other ailments.


One such amendment, sponsored by Rep. Dan Crenshaw, sought to create a DOD grant program funding research on the therapeutic benefits of psilocybin and MDMA for treating PTSD and traumatic brain injury (TBI). 

Surprisingly, this proposal garnered support from both Democrats and Republicans, only to be dismissed due to stricter oversight requirements. The decision highlights the government's enduring failure to recognize the urgent need for innovative solutions in veterans' healthcare.

Additionally, a cannabis-related amendment, put forth by House Veterans Affairs Chair Mark Takano, proposed establishing a medical cannabis pilot program for veterans in the VA health care system. This initiative aimed to grant access to medical cannabis for veterans diagnosed with PTSD, depression, or anxiety. 

Nevertheless, it was also blocked from inclusion in the NDAA, denying veterans a potentially safer and more effective alternative to traditional treatments.

These decisions are a blow to the countless veterans who have found relief and improved quality of life through the use of cannabis and psychedelics. Multiple studies, including a recent survey of over 500 military veterans, demonstrate that medicinal cannabis can lead to a greater quality of life and a reduced reliance on prescription and over-the-counter medications. It is disheartening to see the government overlook such compelling evidence in favor of over-politicized and antiquated stances on cannabis and psychedelics.

The consequences of these omissions are far-reaching. Veterans are left to grapple with debilitating conditions, struggling to access effective treatment options. For those who have exhausted traditional remedies, cannabis and psychedelics offer new hope, paving the way for innovative approaches in managing mental health issues.

Moreover, veterans are being denied access to potential breakthroughs in mental health treatments. Rep. Ken Buck's proposal, which recommended recognizing MDMA as a viable treatment for PTSD, aimed to push the Department of Veterans Affairs (VA) to develop a plan for its approval. This decision represents a missed opportunity to explore promising avenues of healing for our brave servicemen and women.

Congress must acknowledge the growing support for marijuana reform and the positive impact it has on veterans. Medicinal cannabis can serve as a crucial harm-reduction tool, reducing the need for numerous pharmaceutical medications and other substances that often come with dangerous side effects. Veterans deserve access to alternative treatments that have shown real promise in alleviating their suffering.

It is long-past time for the government to prioritize the well-being of our veterans over outdated misconceptions about cannabis and psychedelics. By supporting these and similar amendments, Congress can take a significant step towards honoring the service and sacrifice of our veterans. Failure to do so will perpetuate the government's neglect of the very heroes it should be standing beside. 

As the debates on marijuana reform and psychedelics continue, we implore Congress to seize the opportunity to enact meaningful change for veterans. Let us not overlook the overwhelmingly positive results veterans have experienced firsthand with both cannabis and psychedelics. By including these amendments in the NDAA, our government can finally demonstrate its unwavering commitment to those who have risked their lives to protect our nation's freedom. 

Additional information on Marijuana and Veterans is available from the NORML Fact Sheet, Marijuana and Veterans Issues.’

More For You

map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct

Legal Weed, Legit?

New York’s legal cannabis industry was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report byThe New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call inversion—and it’s been the industry’s not-so-secret open secret for years.

Keep ReadingShow less
Transparency in NY's Cannabis Market: The NYMCIA Controversy
Transparency in NY's Cannabis Market: The NYMCIA Controversy
Transparency in NY's Cannabis Market: The NYMCIA Controversy

Selective Outrage Hurts NY Cannabis

Authored by: Veterans Holdings CEO Jason Ambrosino

Last week, the New York Medical Cannabis Industry Association (NYMCIA) issued a press release accusing licensed dispensaries of selling "out-of-state cannabis" and undermining the integrity of the legal market. Read the press release here.

Keep ReadingShow less
image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less